Related Experiment Videos
A cell-based screen for modulators of ataxin-1 phosphorylation
Michael D Kaytor1, Courtney E Byam, Susan K Tousey
1Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.
Human Molecular Genetics
|March 11, 2005
Summary
Researchers identified pathways regulating serine 776 (S776) phosphorylation in ataxin-1. Inhibitors of the PI3K/Akt pathway reduced mutant ataxin-1 phosphorylation, offering potential therapeutic leads for spinocerebellar ataxia type 1 (SCA1).
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disorder caused by expanded polyglutamine repeats in ataxin-1.
- Phosphorylation of serine 776 (S776) in ataxin-1 influences its pathogenicity.
- Understanding the pathways regulating ataxin-1 phosphorylation is crucial for SCA1 research.
Purpose of the Study:
- To develop a cell-based assay for screening modulators of ataxin-1 S776 phosphorylation.
- To identify signaling pathways involved in ataxin-1 phosphorylation.
- To explore potential therapeutic targets for SCA1.
Main Methods:
- Developed a cell-culture assay using EGFP-ataxin-1 fusion protein and a phospho-S776 specific antibody (PN1168).
- Screened a library of 84 kinase and phosphatase inhibitors.
- Analyzed the effects of inhibitors on ataxin-1 S776 phosphorylation in wild-type and mutant forms.
Main Results:
- Calcium signaling pathways were found to phosphorylate both wild-type and mutant ataxin-1.
- Inhibitors of the PI3K/Akt pathway significantly reduced phosphorylation of mutant ataxin-1.
- Identified specific kinase and phosphatase inhibitors that modulate ataxin-1 phosphorylation.
Conclusions:
- The study provides novel molecular tools for investigating ataxin-1 phosphorylation.
- Calcium and PI3K/Akt signaling pathways play roles in ataxin-1 phosphorylation.
- Targeting the PI3K/Akt pathway may offer a therapeutic strategy for SCA1.